NE
NASDAQ · NEUP
Neuphoria Therapeutics Inc.
Healthcare · Medical - Pharmaceuticals
$3.76
Up+$0.04 (+0.93%)
Updated Sep 4, 2026, 1:39 PM
SID Score
3.0/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 7.4M
- P/E ratio
- -0.02
- Dividend yield
- 0.00%
- 52-week range
- $3.19 – $5.53
- Volume
- 7.46K
- Avg. volume
- 1.58M
Price performance
NEUP price history
1M range · 21 trading sessions · Daily adjusted prices
NEUP closed at $3.76 after 21 trading sessions, down 3.59% for the selected period.
- Last close
- $3.76
- Period change
- -3.59%
- Period low
- $3.75
- Period high
- $3.98
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 3, 2026 | $3.84 | $3.84 | $3.7418 | $3.76 | 7.46K |
| Sep 2, 2026 | $3.84 | $3.84 | $3.75 | $3.75 | 17.95K |
| Sep 1, 2026 | $3.73 | $3.81 | $3.73 | $3.79 | 20.83K |
| Aug 31, 2026 | $3.71 | $3.815 | $3.71 | $3.76 | 52.2K |
| Aug 28, 2026 | $3.72 | $3.835 | $3.72 | $3.76 | 29.91K |
| Aug 27, 2026 | $3.84 | $3.90 | $3.71 | $3.77 | 50.11K |
| Aug 26, 2026 | $3.86 | $3.995 | $3.8537 | $3.86 | 41.03K |
| Aug 25, 2026 | $3.93 | $3.96 | $3.85 | $3.86 | 33.65K |
| Aug 24, 2026 | $3.8999 | $4.0101 | $3.8999 | $3.95 | 58.03K |
| Aug 21, 2026 | $3.9799 | $4.05 | $3.91 | $3.91 | 179.82K |
| Aug 20, 2026 | $3.98 | $4.00 | $3.92 | $3.95 | 55.68K |
| Aug 19, 2026 | $4.03 | $4.03 | $3.93 | $3.93 | 24K |
| Aug 18, 2026 | $3.85 | $4.34 | $3.83 | $3.98 | 240.46K |
| Aug 17, 2026 | $3.91 | $3.97 | $3.7806 | $3.85 | 23.1K |
| Aug 14, 2026 | $3.83 | $3.90 | $3.80 | $3.87 | 23.71K |
| Aug 13, 2026 | $3.77 | $3.88 | $3.77 | $3.83 | 8.92K |
| Aug 12, 2026 | $3.79 | $3.87 | $3.75 | $3.81 | 33.77K |
| Aug 11, 2026 | $3.81 | $3.86 | $3.80 | $3.81 | 30.36K |
| Aug 10, 2026 | $3.81 | $3.89 | $3.81 | $3.86 | 15.5K |
| Aug 7, 2026 | $3.88 | $3.98 | $3.82 | $3.82 | 9.55K |
| Aug 6, 2026 | $3.92 | $4.10 | $3.83 | $3.90 | 29.71K |
Latest NEUP news
The latest Smart Investors Daily articles mentioning NEUP.
Stock researchResearch & News · SEC Filings
Loading stock research…
